PD-0749 Systemic treatment and ablative therapies in oligometastatic breast cancer: a single center analysis

Autor: G. Glemarec, J.L. Lacaze, B. Cabarrou, R. Aziza, E. Jouve, S. Zerdoud, E. De Maio, C. Massabeau, M. Loo, V. Esteyrie, M. Ung, F. Dalenc, F. Izar, C. Chira

Publikováno v: Radiotherapy and Oncology. 170:S661-S662

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d9cb500be0413d942e639a60145c7c27
https://doi.org/10.1016/s0167-8140(22)02944-9

320P Oligometastatic breast cancer incidence and clinical presentation at diagnosis: About 131 cases

Autor: Mony Ung, R. Aziza, F. Izar, G. Glemarec, Florence Dalenc, Eva Jouve, Jean-Louis Lacaze, Anne Pradines, C.I. Chira, Gabrielle Selmes, C. Massabeau, E. De Maio, Slimane Zerdoud

Publikováno v: Annals of Oncology. 31:S371

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::55cdaa299d55791746ef5442824f0034
https://doi.org/10.1016/j.annonc.2020.08.422

P2.06-36 EORTC 1205: Randomized Phase II Study of Pleurectomy/Decortication Preceded or Followed by Chemotherapy in Early Stage MPM

Autor: Jo Raskin, E. De Maio, Baktiar Hasan, V. Surmont, P. Van Schil, J. Van Meerbeeck

Publikováno v: Journal of Thoracic Oncology. 13:S756-S757

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::72f88ef5d6bd4b2737f79a6994e30ee7
https://doi.org/10.1016/j.jtho.2018.08.1291

Diversity of brain metastasis (BM) management in non-small cell lung cancer (NSCLC) in Europe (EU): Results of the Young Investigators European Organisation for Research and Treatment of Cancer Lung Cancer Group (YI EORTC LCG) survey

Autor: Antonin Levy, A-M.C. Dingemans, Lizza E.L. Hendriks, E. De Maio, Corinne Faivre-Finn, Anna S. Berghoff, Baktiar Hasan, Silvia Novello, Thierry Berghmans, Benjamin Besse

Publikováno v: Hendriks, L, Faivre-Finn, C, Hasan, B, de Maio, E, Berghoff, A, Dingemans, A-M, Novello, S, Berghmans, T, Besse, B & Levy, A 2017, ' Diversity of brain metastasis (BM) management in non-small cell lung cancer (NSCLC) in Europe (EU): Results of the Young Investigators European Organisation for Research and Treatment of Cancer Lung Cancer Group (YI EORTC LCG) survey ' . https://doi.org/10.1093/annonc/mdx380.073

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3da6c8dd5986e5aa2acce6921f089e5f
https://doi.org/10.1093/annonc/mdx380.073

Consequences of targeted treatments for second-line therapy

Autor: Samanta Cupini, Carmelo Tibaldi, C. Barbara, Lorenza Landi, E. De Maio, Gabriele Minuti, Armida D'Incecco, Federico Cappuzzo, S. Bursi, R. Di Marsico, M. D'Arcangelo

Publikováno v: Annals of Oncology. 21:vii234-vii240

The paradigm for first-line treatment of relapsed or metastatic non-small cell lung cancer (NSCLC) is changing. Large phase III trials demonstrated that, in 2010, we cannot select a therapy without an accurate definition of tumor histology and epider

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b51285f8387da2d2534e89f29a678df
https://doi.org/10.1093/annonc/mdq280